Health Condition 1: D3A0- Benign carcinoid tumors Health Condition 2: D152- Benign neoplasm of mediastinum Health Condition 3: D150- Benign neoplasm of thymus Health Condition 4: B440- Invasive pulmonary aspergillosis Health Condition 5: C381- Malignant neoplasm of anterior mediastinum Health Condition 6: C34- Malignant neoplasm of bronchus andlung Health Condition 7: C382- Malignant neoplasm of posterior mediastinum Health Condition 8: C37- Malignant neoplasm of thymus Health Condition 9: D491-
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. All elective patients undergoing thoracic procedures broadly involving broncho-pulmonary, mediastinal, chestwall, pleural based pathologies by either open or minimally invasive approach (VATS) at our centre. 2. Patient age group between 16-65 years. 3. All patients who give consent for participation in the study.
Exclusion criteria
Exclusion criteria: 1. Patients unfit for general anaesthesia. 2. Emergency/Semi emergency thoracic surgeries. 3. Oesophageal surgeries. 4. Diaphragmatic surgeries.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To study the postoperative morbidity (30 day morbidity, graded according to Clavein-Dindo system) after application of ERAS protocol in patients undergoing elective general thoracic surgery. 2. To study the postoperative length of hospital stay for patients undergoing general thoracic surgeries after application of ERAS protocol. 3. To study the 30 day readmission rates for patients undergoing general thoracic surgeries after application of ERAS protocolTimepoint: 1. To study the postoperative morbidity (30 day morbidity, graded according to Clavein-Dindo system) after application of ERAS protocol in patients undergoing elective general thoracic surgery. 2. To study the postoperative length of hospital stay for patients undergoing general thoracic surgeries after application of ERAS protocol. 3. To study the 30 day readmission rates for patients undergoing general thoracic surgeries after application of ERAS protocol | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To study the reoperation rates (within 08 weeks) in these patients. 2. To audit the rates of compliance in following the ERAS protocol for patients included in the study.Timepoint: 1. To study the reoperation rates (within 08 weeks) in these patients. 2. To audit the rates of compliance in following the ERAS protocol for patients included in the study. | — |
Countries
India
Contacts
ALL INDIA INSTITUTE OF MEDICAL SCIENCES